Summary:
Florida Pulmonary Research Institute is conducting a study for the safety of a medium dose inhaled Corticosteroid long-acting agonist in patients with uncontrolled Asthma.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Have documented treatment with medium dose ICS fluticasone dry powder formulation and a LABA, for at least 12 months prior to visit 1
•
Have at least 2 documented asthma exacerbations in the past 12 months
Qualified Participants May Receive:
Compensation for time and travel.